Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (26 ops.)
Latest filing published 28 Aug 2026 for Relay Therapeutics, Inc., €77k. Read the official filing
Filing timeline
BuySalePeter Rahmer
Insider track record
Disclosed buys
0
Disclosed sells
26
Signal history
Peter Rahmer: trading record in brief
Peter Rahmer is a declared insider of Relay Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 32 filings cover trades dated from 17 January 2023 to 26 August 2026.
No open-market purchase appears, only 26 sales worth €602k. Besides market trades, the filings include 6 share grants. So far in 2026, the count stands at no purchases and 3 sales.
The latest filing, published on 28 August 2026, reports an open-market sale of €77k in Relay Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Peter Rahmer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
4,508 shares@ US$20.030.0022% mcap12.2% of flowCommon StockSEC:0001193125-26-374645:0
748 shares@ US$18.610.0004% mcap1.9% of flowCommon StockSEC:0001193125-26-326142:0
753 shares@ US$14.790.0003% mcap1.5% of flowCommon StockSEC:0001193125-26-197415:0
994 shares@ US$2.990.4% of flowCommon StockSEC:0001193125-26-029412:0
19,135 shares@ US$7.2918.9% of flowCommon StockSEC:0001193125-25-258595:0
1,359 shares@ US$3.740.7% of flowCommon StockSEC:0000950170-25-100367:0
5,000 shares@ US$2.942.0% of flowCommon StockSEC:0000950170-25-092315:0
1,364 shares@ US$3.170.6% of flowCommon StockSEC:0000950170-25-061367:0
247 shares@ US$2.840.1% of flowCommon StockSEC:0000950170-25-047743:0
1,673 shares@ US$4.631.2% of flowCommon StockSEC:0000950170-25-011335:0
32,156 shares@ US$4.1520.3% of flowCommon StockSEC:0000950170-25-002500:0
400 shares@ US$4.380.3% of flowCommon StockSEC:0000950170-24-141596:0
1,621 shares@ US$6.061.4% of flowCommon StockSEC:0000950170-24-118985:0
245 shares@ US$7.510.3% of flowCommon StockSEC:0000950170-24-110811:0
1,359 shares@ US$8.851.8% of flowCommon StockSEC:0000950170-24-088813:0
245 shares@ US$6.260.2% of flowCommon StockSEC:0000950170-24-079691:0
19,864 shares@ US$6.4718.6% of flowCommon StockSEC:0000950170-24-069553:0
1,345 shares@ US$6.381.3% of flowCommon StockSEC:0000950170-24-050152:0
298 shares@ US$7.700.3% of flowCommon StockSEC:0000950170-24-038654:0
1,651 shares@ US$9.642.3% of flowCommon StockSEC:0001209191-24-002474:0
200,000 shares0Common StockSEC:0001209191-24-001847:0
244 shares@ US$11.510.4% of flowCommon StockSEC:0001209191-23-060000:0
1,354 shares@ US$6.031.2% of flowCommon StockSEC:0001209191-23-054027:0
1,662 shares@ US$10.682.6% of flowCommon StockSEC:0001209191-23-050866:0
1,352 shares@ US$11.802.3% of flowCommon StockSEC:0001209191-23-043850:0
25 of 32 declarations
